RecruitingNot Applicable

Instant Message-delivered Personalised Acceptance and Commitment Therapy (IMPACT) for Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment

Hong Kong160 participantsStarted 2025-12-08

Plain-language summary

This study aims to develop an automated instant message-delivered intervention (i.e., EMI) for people with mild cognitive impairment, and to investigate the feasibility and effectiveness of the intervention.

Who can participate

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Community-dwelling adults aged ≥ 50 years * HK-MoCA score ranged from 18 to 22 * MBI-C ≥7 * SCD-9 ≥3 * IADL \<18 * Able to read and communicate in Chinese * Able to use the text or voice messaging function on a smartphone Exclusion Criteria: * Clinical diagnosis of dementia * Clinical diagnosis of psychiatric disease * Currently participating in any type of psychological or behavioural intervention for NPSs * Currently taking psychiatric medication * Currently receiving acute care or post-acute hospitalization care

What they're measuring

MBI-C scores

Timeframe: at 2nd and 6th months

Trial details

NCT IDNCT07420426

SponsorThe University of Hong Kong

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10-02

Contact for this trial

Doris Sau Fung Yu, Professor

+852 3917 6319 dyu1@hku.hk

View on ClinicalTrials.gov More Mild Cognitive Impairment (MCI) trials